Aequs IPO opens for subscription from December 3 to 5, 2025, with allotment on December 8 and listing on BSE and NSE on December 10, 2025. The book-built issue totals ₹921.81 crore, comprising a fresh issue of ₹670 crore and an offer for sale of ₹251.81 crore. Aequs specializes in precision engineering and aerospace manufacturing, operating India’s largest SEZ-based private aero structure facility with over 200 CNC machines. The Aequs IPO offers investors entry into high-growth aerospace and defence manufacturing amid India’s self-reliance push.
₹40
₹124
₹
Expert Opinions
Market sentiment for Aequs IPO is positive, driven by investor interest in aerospace manufacturing, despite the company reporting losses in FY 2025. Company strengths include its status as India’s largest SEZ-based private aero structure facility, advanced CNC machining capabilities, and a strong client base including Airbus and Boeing. Risks involve continued losses with Return on Equity (ROE) at -14.30%, low ROCE of 0.87%, client concentration, and working capital intensity.
Valuation analysis of Aequs IPO and year 2025 reveals a Net Asset Value (NAV) of ₹12.47, reflecting low asset turnover and capital inefficiency. Long-term investment perspective hinges on growth prospects tied to India’s defense manufacturing push, advanced production scaling, and order book expansion, but investors should be cautious of profitability and execution risks.
Investor Considerations
Aequs IPO investors should assess the company’s challenging fundamentals, reporting revenue decline of 4% to ₹924.61 crore and a net loss widening to ₹102.35 crore in FY 2025. The aerospace and precision manufacturing sector outlook remains robust, propelled by India’s defence localization and global supply chain shifts. Valuation analysis for Aequs IPO in 2025 shows a Price to Book Value of 9.94, PAT Margin of -11.07%, and Debt/Equity ratio of 0.99, signaling premium pricing amid persistent losses and moderate leverage.
Growth prospects involve capacity expansion via CNC machines and new consumer segments. Risks include ongoing unprofitability, client concentration with Airbus/Boeing, and elongated working capital cycles. Long-term investors may capture aerospace tailwinds, while short-term goals face volatility from execution uncertainties.
FAQs
Aequs IPO Current GMP is ₹40.
Aequs IPO Expected Returns is 32.26%.
Aequs IPO estimated listing price is ₹164.